|Articles|April 8, 2012
What Does Overturning ACA Mean to Pharma?
Author(s)Christopher Allen
In contentious three days of hearing on the Affordable Care Act, the Supreme Court now seems far more likely to overturn the landmark legislation.
Advertisement
Guest blog written by Reid Paul.
In contentious three days of hearing on the Affordable Care Act, the Supreme Court now seems far more likely to overturn the landmark legislation. Given the strong support the bill originally received from the industry, does overturning it benefit or hurt pharma?
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
2
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
3
Momentum and Automation Driving Pharma Innovation and Digitalization Through 2026
4
Johnson & Johnson’s Tecvayli Combo Wins FDA National Priority Voucher
5